Brind.

MAPS commented on FDA's CRL release following a statement involving FDA Commissioner Makary and HHS Secretary Kennedy.

2 reports, 1 independent Updated Sep 5

Gone quiet

Reports: 2
Developments: 1
Repetition: 50%

New informationRepeats or wire copies

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

MAPS commented on FDA's CRL release following a statement involving FDA Commissioner Makary and HHS Secretary Kennedy.

Who's involved

What this event is mainly about

FDA Makary Maps

Keep exploring

The entities involved

FDA
- Generic medicine services are seeking approval for launch from the FDA.Mon 17:49
- A company is seeking FDA feedback on its NEO212 program, with a meeting scheduled at the FDA's White Oak campus.Mon 14:56
Makary
Nothing else this week.
Maps
British musician

Nothing else this week.

Coverage

Newest first; wire copies grouped

Sep 5GlobeNewswireMAPS Statement on FDA’s Public Release of Complete Response Letter for MDMA-assisted Therapy SAN JOSE, Calif., Sept. 04, 2025 (GLOBE NEWSWIRE) -- In August 2024, the U.S. Food and Drug Administration
Aug 27GlobeNewswireMAPS Partners with Changemark to Advance Cannabis PTSD Research for Veterans MAPS takes critical step toward beginning formal site selection and recruitment for MJP2, a Phase 2 study of inhaled canna